GATA3 and breast carcinoma: FOXA1 binding sites are known to define lineage-specific enhancers in luminal breast cancer cells [29] and several luminal-specific transcription factor motifs (GATA3, TRPS1, etc.)[30] were also significantly enriched in the set of differentially accessibly ATAC-seq sites (Fig 4A).